A Trial to Assess Safety and Efficacy of Topical MBN-101 in Patients With Moderate/ Severe DFI
Clinical trial NCT02723539 · COMPLETED
Trial details
- NCT number
- NCT02723539
- Sponsor
- Microbion Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-06
- Primary completion
- 2017-11-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.